Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Vermindering hersendoorbloeding en achteruitgang van cognitie bij Alzheimer
mei 2022 | Dementie